Abrol (ambroxol) tablets 30 mg. №20

$5.00

Manufacturer: Ukraine

Purpose: Abrol (ambroxol) thins mucus to ease coughing and respiratory congestion.

SKU: MED56186 Category:

Description

Abrol (ambroxol) tablets 30 mg. №20

Ingredients

Active ingredient: Ambroxol hydrochloride 30 mg per tablet.

Dosage

Recommended dosage: 1 tablet three times a day. Do not exceed the stated dose.

Indications

Abrol tablets are indicated for the treatment of respiratory conditions associated with viscid mucus, such as acute and chronic bronchitis, asthma, and bronchiectasis.

Contraindications

Do not use Abrol tablets if you are allergic to ambroxol or any other ingredients in the formulation. Consult a healthcare professional before use if you are pregnant or breastfeeding.

Directions

Swallow the tablets whole with a glass of water. It is recommended to take the tablets with food to minimize the risk of gastrointestinal upset.

Scientific Evidence

Ambroxol has been extensively studied for its mucolytic and expectorant properties. Research has shown that ambroxol helps to reduce the viscosity of mucus, making it easier to clear from the airways. Clinical trials have demonstrated the efficacy of ambroxol in improving respiratory symptoms and lung function in patients with various respiratory conditions.

Additional Information

Store in a cool, dry place away from direct sunlight. Keep out of reach of children. If symptoms persist, consult a healthcare professional.

Pharmacological Effects: Ambroxol works by stimulating the production of surfactant in the lungs, which helps to keep the airways open and clear. It also acts as a mucolytic agent, breaking down thick mucus and facilitating its removal from the respiratory tract.

Clinical Trials: A study published in the International Journal of Chronic Obstructive Pulmonary Disease found that ambroxol improved lung function and quality of life in patients with chronic bronchitis. Another study in the European Respiratory Journal showed that ambroxol was effective in reducing exacerbations in patients with asthma.